Literature DB >> 18625706

Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy.

Chinmay M Trivedi1, Min Min Lu, Qiaohong Wang, Jonathan A Epstein.   

Abstract

Class I and II histone deacetylases (HDACs) play vital roles in regulating cardiac development, morphogenesis, and hypertrophic responses. Although the roles of Hdac1 and Hdac2, class I HDACs, in cardiac hyperplasia, growth, and hypertrophic responsiveness have been reported, the role in the heart of Hdac3, another class I HDAC, has been less well explored. Here we report that myocyte-specific overexpression of Hdac3 in mice results in cardiac abnormalities at birth. Hdac3 overexpression produces thickening of ventricular myocardium, especially the interventricular septum, and reduction of both ventricular cavities in newborn hearts. Our data suggest that increased thickness of myocardium in Hdac3-transgenic (Hdac3-Tg) mice is due to increased cardiomyocyte hyperplasia without hypertrophy. Hdac3 overexpression inhibits several cyclin-dependent kinase inhibitors, including Cdkn1a, Cdkn1b, Cdkn1c, Cdkn2b, and Cdkn2c. Hdac3-Tg mice did not develop cardiac hypertrophy at 3 months of age, unlike previously reported Hdac2-Tg mice. Further, Hdac3 overexpression did not augment isoproterenol-induced cardiac hypertrophy when compared with wild-type littermates. These findings identify Hdac3 as a novel regulator of cardiac myocyte proliferation during cardiac development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625706      PMCID: PMC2546558          DOI: 10.1074/jbc.M803686200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  CoREST is an integral component of the CoREST- human histone deacetylase complex.

Authors:  A You; J K Tong; C M Grozinger; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  HDAC inhibitors overcome first hurdle.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2007-01-05       Impact factor: 54.908

Review 3.  Anticancer activities of histone deacetylase inhibitors.

Authors:  Jessica E Bolden; Melissa J Peart; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

Review 4.  Can the cardiomyocyte cell cycle be reprogrammed?

Authors:  Katrina A Bicknell; Carmen H Coxon; Gavin Brooks
Journal:  J Mol Cell Cardiol       Date:  2007-01-24       Impact factor: 5.000

5.  Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility.

Authors:  Rusty L Montgomery; Christopher A Davis; Matthew J Potthoff; Michael Haberland; Jens Fielitz; Xiaoxia Qi; Joseph A Hill; James A Richardson; Eric N Olson
Journal:  Genes Dev       Date:  2007-07-15       Impact factor: 11.361

Review 6.  Cardiac myocyte cell cycle control in development, disease, and regeneration.

Authors:  Preeti Ahuja; Patima Sdek; W Robb MacLellan
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

7.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness.

Authors:  M G Guenther; W S Lane; W Fischle; E Verdin; M A Lazar; R Shiekhattar
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

8.  Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.

Authors:  Chinmay M Trivedi; Yang Luo; Zhan Yin; Maozhen Zhang; Wenting Zhu; Tao Wang; Thomas Floss; Martin Goettlicher; Patricia Ruiz Noppinger; Wolfgang Wurst; Victor A Ferrari; Charles S Abrams; Peter J Gruber; Jonathan A Epstein
Journal:  Nat Med       Date:  2007-02-18       Impact factor: 53.440

9.  Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium.

Authors:  Chinmay M Trivedi; Rekha C Patel; Chandrashekhar V Patel
Journal:  Atherosclerosis       Date:  2007-06-27       Impact factor: 5.162

Review 10.  Histone deacetylase inhibitors: molecular mechanisms of action.

Authors:  W S Xu; R B Parmigiani; P A Marks
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

View more
  51 in total

Review 1.  Multiple roles of class I HDACs in proliferation, differentiation, and development.

Authors:  Nina Reichert; Mohamed-Amin Choukrallah; Patrick Matthias
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

2.  Histone deacetylase 3 regulates smooth muscle differentiation in neural crest cells and development of the cardiac outflow tract.

Authors:  Nikhil Singh; Chinmay M Trivedi; MinMin Lu; Shannon E Mullican; Mitchell A Lazar; Jonathan A Epstein
Journal:  Circ Res       Date:  2011-09-29       Impact factor: 17.367

Review 3.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

4.  Inpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsiveness.

Authors:  Wenting Zhu; Chinmay M Trivedi; Diane Zhou; Lijun Yuan; Min Min Lu; Jonathan A Epstein
Journal:  Circ Res       Date:  2009-10-29       Impact factor: 17.367

5.  Epicardial-derived adrenomedullin drives cardiac hyperplasia during embryogenesis.

Authors:  Sarah E Wetzel-Strong; Manyu Li; Klara R Klein; Toshio Nishikimi; Kathleen M Caron
Journal:  Dev Dyn       Date:  2014-02       Impact factor: 3.780

6.  Targeted deletion of Tsc1 causes fatal cardiomyocyte hyperplasia independently of afterload.

Authors:  Usamah S Kayyali; Christopher G Larsen; Sarah Bashiruddin; Sara L Lewandowski; Chinmay M Trivedi; Rod R Warburton; Andrey A Parkhitko; Tasha A Morrison; Elizabeth P Henske; Yvonne Chekaluk; David J Kwiatkowski; Geraldine A Finlay
Journal:  Cardiovasc Pathol       Date:  2014-11-07       Impact factor: 2.185

Review 7.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 8.  HDAC-dependent ventricular remodeling.

Authors:  Min Xie; Joseph A Hill
Journal:  Trends Cardiovasc Med       Date:  2013-03-15       Impact factor: 6.677

9.  Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium.

Authors:  Ling X Zhang; Jianfeng Du; Yu Tina Zhao; Jianguo Wang; Shouyan Zhang; Patrycja M Dubielecka; Lei Wei; Shougang Zhuang; Gangjian Qin; Y Eugene Chin; Ting C Zhao
Journal:  J Appl Physiol (1985)       Date:  2018-10-04

Review 10.  Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.

Authors:  Hae Jin Kee; Hyun Kook
Journal:  J Biomed Biotechnol       Date:  2010-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.